BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 35062904)

  • 1. Statin use is associated with the reduction in hepatocellular carcinoma recurrence after liver surgery.
    Khajeh E; Moghadam AD; Eslami P; Ali-Hasan-Al-Saegh S; Ramouz A; Shafiei S; Ghamarnejad O; Dezfouli SA; Rupp C; Springfeld C; Carvalho C; Probst P; Mousavizadeh SM; Mehrabi A
    BMC Cancer; 2022 Jan; 22(1):91. PubMed ID: 35062904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin use is associated with a lower risk of recurrence after curative resection in BCLC stage 0-A hepatocellular carcinoma.
    Yang SY; Wang CC; Chen KD; Liu YW; Lin CC; Chuang CH; Tsai YC; Yao CC; Yen YH; Hsiao CC; Hu TH; Tsai MC
    BMC Cancer; 2021 Jan; 21(1):70. PubMed ID: 33446127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin use is associated with a reduced risk of hepatocellular carcinoma recurrence after initial liver resection.
    Kawaguchi Y; Sakamoto Y; Ito D; Ito K; Arita J; Akamatsu N; Kaneko J; Hasegawa K; Moriya K; Kokudo N
    Biosci Trends; 2017 Nov; 11(5):574-580. PubMed ID: 29081488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticancer Effect of Statins in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma.
    Lee HL; Lee SW; Jang JW; Bae SH; Choi JY; Yoon SK; Choi HJ; Na GH; You YK; Park IY; Kim DG
    Liver Transpl; 2022 Mar; 28(3):397-406. PubMed ID: 34374192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of perioperative use of statins, metformin, and aspirin with recurrence after curative liver resection in patients with hepatocellular carcinoma: A propensity score matching analysis.
    Khajeh E; Aminizadeh E; Moghadam AD; Ramouz A; Klotz R; Golriz M; Merle U; Springfeld C; Chang DH; Longerich T; Büchler MW; Mehrabi A
    Cancer Med; 2023 Oct; 12(19):19548-19559. PubMed ID: 37737550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin use is associated with better post-operative prognosis among patients with hepatitis B virus-related hepatocellular carcinoma.
    Yun B; Ahn SH; Oh J; Yoon JH; Kim BK
    Eur J Clin Invest; 2023 Apr; 53(4):e13936. PubMed ID: 36504405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin attenuates cell proliferative ability via TAZ (WWTR1) in hepatocellular carcinoma.
    Higashi T; Hayashi H; Kitano Y; Yamamura K; Kaida T; Arima K; Taki K; Nakagawa S; Okabe H; Nitta H; Imai K; Hashimoto D; Chikamoto A; Beppu T; Baba H
    Med Oncol; 2016 Nov; 33(11):123. PubMed ID: 27734263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transarterial chemoembolization versus hepatic resection in hepatocellular carcinoma treatment: a meta-analysis.
    Tian X; Dai Y; Wang DQ; Zhang L; Sui CG; Meng FD; Jiang SY; Liu YP; Jiang YH
    Drug Des Devel Ther; 2015; 9():4431-40. PubMed ID: 26309396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of statins on the recurrence of hepatocellular carcinoma after liver transplantation: An illusion revealed by exposure density sampling.
    Kim DG; Yim SH; Min EK; Choi MC; Kim MS; Joo DJ; Lee JG
    Liver Int; 2023 Sep; 43(9):2017-2025. PubMed ID: 37365992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin Use is Associated with Decreased Hepatocellular Carcinoma Recurrence in Liver Transplant Patients.
    Cho Y; Kim MS; Nam CM; Kang ES
    Sci Rep; 2019 Feb; 9(1):1467. PubMed ID: 30728421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation.
    Lee O; Rhu J; Choi GS; Kim JM; Kim K; Joh JW
    Ann Transplant; 2022 Apr; 27():e935604. PubMed ID: 35379768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin is associated with low recurrent risk in hepatitis B virus-related hepatocellular carcinoma patients after curative resection.
    Young SH; Chau GY; Lee IC; Yeh YC; Chao Y; Huo TI; Su CW; Lin HC; Hou MC; Lee MH; Huang YH
    J Formos Med Assoc; 2020 Jan; 119(1 Pt 2):218-229. PubMed ID: 31104872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of laparoscopic vs open liver resection for hepatocellular carcinoma.
    Xiong JJ; Altaf K; Javed MA; Huang W; Mukherjee R; Mai G; Sutton R; Liu XB; Hu WM
    World J Gastroenterol; 2012 Dec; 18(45):6657-68. PubMed ID: 23236242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis: Chemoprevention of hepatocellular carcinoma with statins, aspirin and metformin.
    Zeng RW; Yong JN; Tan DJH; Fu CE; Lim WH; Xiao J; Chan KE; Tan C; Goh XL; Chee D; Syn N; Tan EX; Muthiah MD; Ng CH; Tamaki N; Lee SW; Kim BK; Nguyen MH; Loomba R; Huang DQ
    Aliment Pharmacol Ther; 2023 Mar; 57(6):600-609. PubMed ID: 36625733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of vitamin K2 in preventing the recurrence of hepatocellular carcinoma after curative treatment: a meta-analysis of randomized controlled trials.
    Riaz IB; Riaz H; Riaz T; Rahman S; Amir M; Badshah MB; Kazi AN
    BMC Gastroenterol; 2012 Nov; 12():170. PubMed ID: 23191943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma cases with high levels of c-Raf-1 expression may benefit from postoperative adjuvant sorafenib after hepatic resection even with high risk of recurrence.
    Lei J; Zhong J; Hao J; Liu Z; Zhang P; Wu L; Yan L; Zhu J; Zeng Y; Li B; Wen T; Wang W
    Oncotarget; 2016 Jul; 7(27):42598-42607. PubMed ID: 26981887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcome of small hepatocellular carcinoma after different treatments: a meta-analysis.
    Dong W; Zhang T; Wang ZG; Liu H
    World J Gastroenterol; 2014 Aug; 20(29):10174-82. PubMed ID: 25110446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrence of Barcelona Clinic Liver Cancer Stage A Hepatocellular Carcinoma After Hepatectomy.
    Zou H; Zhu CZ; Wang C; Wang ZS; Ma X; Han B; Wu LQ
    Am J Med Sci; 2017 Sep; 354(3):262-267. PubMed ID: 28918833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A meta-analysis of the efficacy and safety of adjuvant sorafenib for hepatocellular carcinoma after resection.
    Huang S; Li D; Zhuang L; Sun L; Wu J
    World J Surg Oncol; 2021 Jun; 19(1):168. PubMed ID: 34112190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes after hepatic resection and subsequent multimodal treatment of recurrence for multifocal hepatocellular carcinoma.
    Kim PT; Jang JH; Atenafu EG; Fischer S; Greig PD; McGilvray ID; Wei AC; Gallinger S; Cleary SP
    Br J Surg; 2013 Oct; 100(11):1516-22. PubMed ID: 24037575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.